Suppressor T cell changes in active multiple sclerosis: analysis with three different monoclonal antibodies

Area of Science:

• Immunology
• Neuroscience
• Cell Biology

Background:

• Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
• T cells, particularly suppressor T cells, play a critical role in immune regulation and have been implicated in MS pathogenesis.
• Previous studies have reported conflicting findings regarding T cell populations in MS patients.

Purpose of the Study:

• To investigate the levels of total T cells and suppressor T cells in multiple sclerosis patients during acute relapse and remission.
• To evaluate the impact of different monoclonal antibodies on the detection of suppressor T cells.

Main Methods:

• Flow cytometry was used to quantify T cell populations.
• Monoclonal antibodies (Leu 2a, OKT 8, OKT 5) were employed to identify and enumerate suppressor T cells.
• Patients were categorized into acute relapse and remission groups.

Main Results:

• A significant reduction in total T cells and suppressor T cells was observed in MS patients during acute relapse compared to those in remission.
• The reduction in suppressor T cells was consistently detected across all three monoclonal antibodies used.
• The monoclonal antibody Leu 2a provided the clearest demonstration of suppressor T cell reduction compared to OKT 8 and OKT 5.

Conclusions:

• Suppressor T cell numbers are significantly decreased in active multiple sclerosis relapses.
• The selection of monoclonal antibody is a critical factor influencing the accurate enumeration of suppressor T cells in MS research.
• Variations in antibody choice may account for discrepancies in previously published data on T cell subsets in multiple sclerosis.